Thyroid nodule historical perspective
Thyroid nodule Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Thyroid nodule historical perspective On the Web |
American Roentgen Ray Society Images of Thyroid nodule historical perspective |
Risk calculators and risk factors for Thyroid nodule historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahshid Mir, M.D. [2]
Overview
Historical perspective
In 2700 BC, seaweed were used for the treatment of goiter.
40 BC Pliny, Vitruvius, and Juvenal describe prevalence of goiter in the Alps and used the burnt seaweed for treatment
138 AD Greek physician, Soranus, mentions neck swelling following pregnancy
340 AD chinese alchemist, Ko-Hung, recommends seaweed for treatment of goiter among people living in mountains.
650 AD another chinese physician, Sun Ssu-Mo used dried, powdered mollisc shells and chopped thyroid gland for the treatment of goiter
961 AD Abul Kasim, a physician in Codoba, was the first to describe thyroidectomy and to perform a needle biopsy
1200 AD Arnaldus de Villanova reported that marine sponges could be used to treat goiters of recent origin in the youngs
1475 AD Wang Hei, a chinese physician recommended treat of goiter with minced thyroid
1500 AD Leonardo da Vinci was the first to recognize and draw the thyroid gland
1543 AD ANdreas Vesalius provides first anatomic description and illustration of the thyroid gland.
1563 AD Eustachius was the first who introduced the term "isthmus" to describe tissue connecting the two lobes of the thyroid
1602 Felix Platter was the first who described cretins found in Valais region of switzerland
Wharton, Thomas 1614-1673 Courtesy of the National Library of Medicine/Thomas Wharton names gland "thyroid" after the shape of an ancient Grecian shield
1669 Albrecht van Haller describes contipation as a complication of cretinism
In 1825, C. Parry describes exophthalmic goiter.
In 1831, Iodine prophylaxis propsed as a goverment-administered public health program, for goiter prevention.
In 1834, Rober Graves described a syndrome of palpitation, goiter, and exophthalmos and called the disease as Grave's disease
In 1857, B. Niepce was the first to describe enlargement of sella turcica in cretins with hypothyroidism in Switzerland.
In 1857, Maurice Schiff was the first to perform a successful total thyroidectomies in animals.
In 1862, A. Trousseau introduced the term "Graves disease" for the disease that was described before bby Grave.
In 1867, A. von Graefe described lid lag in thyrotoxicosis which later was known as Basedow's disease.
In 1873, Th. Billroth was the first to describe tetany following total thyroidectomy.
In 1882, William Ord was the first to describe the term myxedema for a case of a middle aged woman with cretinoid features.
In 1888, Rogowitsch was the first to describe the pituitary hyperplasia in rabbits following thyroidectomy.
In 1891, Victor Horsley was the first to discovered the direct effect of thyroid function deficiency in developing myxedema, cretinism, and post-thyroidecomy cachexia by working on monkeys.
In 1891, G. R. Murray was the first to describe the effect of thyroid extract in treating myxedema
In 1895, Adolf Magnus Levy was the first to describe the influence of the thyroid on the basal metabolic rate
In 1896, B. Riedel was the first to describe chronic fibrous thyroiditis.
In 1898, von Notthalt was the first to describe thyrotoxicosis factitia
In 1902, F. de Quervain was the first that described subacute granulomatous thyroiditis.
In 1905, Dr. Robert Abbe was the first who treated the graves disease by implanting radium into the patients goiter
In 1910, Charles H. Mayo was the first who described the term "hyperthyroidism" for explaining the clinical manifestations of primary exophthalmic goiter, toxic adenoma, and adenomatous goiter with hyperthyroidism.
In 1914, E. C. Kendall was the first who isolated thyroxine
In 1917, M. Seymour in Boston was the first who described the usage of X ray for treating Graves disease.
In 1924, H. S. Plummer at the Mayo clinic was the first who described the pre-operative usage of iodine for Graves disease treatment.
In 1928, Harington and Barger were the first who described the chemical structure of thyroxine and synthesize it.
In 1931, L. Loeb and R. Bassett were the first who extracted and purified TSH from bovine pituitaries.
In 1936, Dr. Saul Hertz was the first who described the usage of radioactive iodine for the study of the thyroid.
In 1946, A. Astwood was the first who used thiourea and thiouracil for medical treatment of graves disease.
In 1947, Cope, Rawson, and McArthur were the first who described the usage of radioactive iodine to demonstrate a "hot" thyroid nodule.
In 1948, T. Templa, J. Aleksandrowicz, and M. Till were the first who described the usage of fine needle thyroid biopsy as a diagnostic method for thyroid nodules.
In 1949, R. G. Hoskins was the first who described negative feedback of thyroid on pituitary, a mechanism that he called "servo (feedback) mechanism"
In 1949, Jones, Kornfeld, McLaughlin, and Anderson were the first who synthesize methimazole.
In 1950, J. B. Stanbury was the first who described the genetic abnormality association with thyroid hormone synthesis.
In 1959, J. B. Hazard, W. A. Hawk, and G. Crile were the first eho described medullary thyroid cancer as a distinct entity.
In 1965, S. Berson and R. Yalow were the first who described radioimmunoassay procedure.
In 1966, R. F. Rohner, J. T. Prior and J. H. Sipple were the first who described multiple endocrine neoplasia type 2 and reported some cases.
In 1970, A. Schally and R. Guillemin were the first who discovered TRH seperately from each other.
In 1998, United States scientists was the first country that approved clinical usage of recombinant human TSH.
Thyroid nodule Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Thyroid nodule historical perspective On the Web |
American Roentgen Ray Society Images of Thyroid nodule historical perspective |
Risk calculators and risk factors for Thyroid nodule historical perspective |